State and DC Legislators Write Senate on Health Reform - Protest Data Exclusivity Provisions for Biogenerics

Nov 20, 2009

National Legislative Association on Prescription Drug Prices sent a letter to Senate Majority Leader Harry Reid urging that he amend the Patient Protection and Affordable Care Act to more directly and effectively lower the cost of pharmaceuticals. The letter included criticism of the biogeneric provisions that would allow brand name firms to use consecutive 12 year periods of data exclusivity to block generic entry.

More...

PIJIP Associate Director Sean Fiil-Flynn to Testify to Maine Judiciary Committee In Support of the Maine Act To Prevent Predatory Marketing Practices Against Minors

Oct 15, 2009

On October 15, 2009, Program on Information Justice and Intellectual Property Associate Director Sean Fiil-Flynn will testify in front of the Maine Judiciary Committee as part of its review of P.L. 2009, c. 230, Maine’s Act To Prevent Predatory Marketing Practices against Minors. The Maine Act limits marketers’ use of personally identifiable data to market to minors.

More...

Possible Ways to Address Roche's Refusal to Sell Fuzeon in Korea

by: Sean Flynn - October 6, 2008 04:28 PM

The recent declaration of Roche that it will refuse to supply the South Korean market with Fuzeon is the second major threat of this kind. Last year, Abbott refused to continue registration applications for several new drugs in response to a compulsory license issued by Thailand on Kaletra.

More... (Comments: 0)

The African Commission and Access to Medicines and Human Rights in Africa

by: Karolina Lyznik - September 15, 2008 10:22 AM

According to a 2006 report by the Special Rapporteur on the Right to Health, Paul Hunt, states have an obligation under the International Covenant on Economic, Social and Cultural Rights (“ICESCR”) to respect, protect, and fulfill the right to health. The majority of African states are parties to the ICESCR, yet this right, particularly with regards to accessibility, is neglected. Many governments cite IP restrictions as the source of the problem, claiming that they limit availability and thereby hinder accessibility, but in many cases these governments have neglected to incorporate the flexibilities provided in TRIPS.

More... (Comments: 0)

Page 8 of 13

« < 3 4 5 6 7 8 9 10 11 12 > »

Access to Medicine Legal Education Initiative

	UNDP, OSI, PIJIP Meeting on Trade Agreements, Intellectual Property, and Access to Medicines, Kiev, Ukraine, 2009 September 21-22, Kiev Ukraine. Participants were drawn from nations undertaking or seriously considering Free Trade Agreement (FTA) negotiations with western nations, or acceding to the World Trade Organization (WTO).

	Kyiv-Mohyla Academy IP and Access to Medicines Training, September 2009 September 14-18, Kiev, Ukriaine. PIJIP, OSI and the Kyiv-Mohyla Academyhosted a training to show advocates from Eastern Europe and the Commonwealth of Independent States how intellectual property flexibilities permitted by international law can be used to promote access to affordable generic medicines.

	2009 Statement of Participants from SADC Parliamentary Training May 12-14, Pretoria, South Africa. A three-day workshop for Parliamentarians from SADC nations was organized by PIJIP, the University of Pretoria, UNDP and OSI. Participants from thirteen countries attended, and issued a joint statement on IP, trade and health.

	African Commission on Human and People's Rights Resolution on Access to Health and Needed Medicines in Africa The 44th Ordinary Session of the African Commission on Human and Peoples' Rights in Abuja, Nigeria has adopted the Resolution on the Right to Health and Access to Needed Medicines in Africa. The resolution was based on the NGO statement produced by clinical students after the previous Access to Medicine Short Course in Pretoria.

	2008 NGO Resolution on Access to Needed Medicines Pretoria and WCL students worked with groups fighting HIV/AIDS on the continent to prepare a resolution calling on the African Commission on Human and Peoples’ Rights to recognize human rights to access needed medicines. It specifically calls on the Commission to take “full advantage of all flexibilities in the WTO Agreement on Trade Related Aspects of Intellectual Property that promote access to affordable medicines.”

	Human Rights and Access to Medicines Short Course, University of Pretoria, 2008 May, 2008. The short course was planned and taught by seven professors and practitioners from six countries. The 46 participants in the course included LLM students from 21 countries, government officials, academics, parliamentarians and activists.

	Clinical Group on Access to Medicine in Africa PIJIP and Pretoria students have created the Clinical Group on Access to Medicine in Africa. They have compiled a large bibliography materials, and have written a white paper, and have worked with African civil society groups to draft a submission to the Commission for its November meeting in Abuja, Nigeria.

	Additional Materials The Human Rights and Access to Medicine Legal Education Initiative has compiled a large amount of resources covering the intersecting areas of intellectual property, human rights obligations, and access to medicines. This page is an ongoing compilation of these materials, including treaties, laws, journal articles, and more.